Werewolf Therapeutics Funding: $56M Raised, Series A (2019)
Werewolf Therapeutics is based in Cambridge. It has raised $56M in total funding. Latest round: Series A.
Werewolf Therapeutics funding overview
Werewolf Therapeutics is based in Cambridge. Werewolf Therapeutics has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2019. The round record for Werewolf Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include MPM Capital, Longwood Fund, Taiho Ventures, Arkin Bio Ventures, UPMC Enterprises, DC Investment Partners. 6 distinct backers are named across the disclosed rounds.
Werewolf Therapeutics at a glance
Total raised
$56M
Latest round
Series A
Latest round date
November 2019
Headquarters
Cambridge
Notable investors
MPM Capital, Longwood Fund, Taiho Ventures, Arkin Bio Ventures, UPMC Enterprises, DC Investment Partners
Frequently asked about Werewolf Therapeutics funding
How much has Werewolf Therapeutics raised?
Werewolf Therapeutics has raised $56M in total disclosed funding across the rounds on record.
Who has invested in Werewolf Therapeutics?
MPM Capital, Longwood Fund, Taiho Ventures, Arkin Bio Ventures, UPMC Enterprises, DC Investment Partners are named among the investors backing Werewolf Therapeutics.
What was the latest Werewolf Therapeutics funding round?
The most recent disclosed round is a Series A, announced in November 2019.
Where is Werewolf Therapeutics based?
Werewolf Therapeutics is based in Cambridge.
When did Werewolf Therapeutics last raise?
The last disclosed Werewolf Therapeutics round closed in November 2019 at Series A.
Round data for Werewolf Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.
